EXN-407

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameEXN-407
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSRSF protein kinase 1 inhibitors
TargetsSRSF protein kinase 1
Therapy Area/IndicationsDiabetic macular oedema
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesExonate Ltd
China Registration ClassN/A

Develop Information

Active CompaniesExonate Ltd
Inactive CompaniesN/A
Active IndicationsDiabetic macular oedema
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A